Cory S. Freedland - Jun 14, 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role
Director
Signature
/s/ Christine Mikail, as attorney-in-fact for Cory S. Freedland
Stock symbol
NGNE
Transactions as of
Jun 14, 2024
Transactions value $
$0
Form type
4
Date filed
6/17/2024, 02:35 PM
Previous filing
Jan 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGNE Stock Option (Right to Buy) Award $0 +7.7K $0.00 7.7K Jun 14, 2024 Common Stock 7.7K $42.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 7,700 shares of the Issuer's common stock, which will vest in its entirety on the earlier of (a) the first anniversary of the date of grant or (b) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such applicable vesting date.